Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

DOI: 10.1530/eje.0.1440561
European Journal of Endocrinology, Vol 144, Issue 6, 561-568
Copyright © 2001 by European Society of Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Andrikoula, M
Right arrow Articles by Tsatsoulis, A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Andrikoula, M
Right arrow Articles by Tsatsoulis, A
Articles

The role of Fas-mediated apoptosis in thyroid disease

M Andrikoula and A Tsatsoulis

Division of Endocrinology, Department of Medicine, University of Ioannina Medical School, Ioannina 45110, Greece.

Recent evidence has emphasized the importance of apoptosis in the maintenance of tissue homeostasis and the pathogenesis of malignant and immune diseases. Autoimmune thyroid diseases such as Hashimoto's thyroiditis and Graves' disease, as well as other autoimmune endocrine diseases, have been associated with dysregulation of apoptotic signaling pathways. In particular, dysfunction of the Fas apoptotic pathway or production of soluble factors including soluble Fas and soluble Fas ligand may be involved in the pathogenesis of these disorders. On the other hand, malignant thyroid cells may avoid Fas-mediated suicide possibly by expression of inhibitors of apoptosis and evade the immune system by inducing apoptosis on infiltrating lymphocytes. The delicate balance between cell proliferation and cell death through the Fas pathway may also play an important role in the control of thyroid cell mass and goitrogenesis. This review analyzes the current evidence on the role of Fas-mediated apoptosis in the pathogenesis of thyroid diseases including Hashimoto's thyroiditis, Graves' disease, thyroid cancer and goiter. However, the exact mechanisms involved in the regulation of apoptosis in thyroid disease remain unclear. Further investigation is needed.


This article has been cited by other articles:


Home page
 Eur J EndocrinolHome page
S. Fountoulakis, G. Vartholomatos, N. Kolaitis, S. Frillingos, G. Philippou, and A. Tsatsoulis
Differential expression of Fas system apoptotic molecules in peripheral lymphocytes from patients with Graves' disease and Hashimoto's thyroiditis.
Eur. J. Endocrinol., June 1, 2008; 158(6): 853 - 859.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
S. Gullu, R. Emral, M. Bastemir, A. B Parkes, and J. H Lazarus
In vivo and in vitro effects of statins on lymphocytes in patients with Hashimoto's thyroiditis
Eur. J. Endocrinol., July 1, 2005; 153(1): 41 - 48.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 European Society of Endocrinology.